COVID-19 Relief Fraud Investigations and Litigation: Areas of Focus and Risk Mitigation Strategies
![Medical Healthcare Science](/sites/default/files/styles/fullscreen_4x3_767x575_1x/public/2024-08/Medical%20Healthcare%20Science.jpg?itok=fS5BQMlq)
In this episode of White Collar Briefly, Perkins Coie's Barak Cohen, David Fletcher, and Alexander Canizares discuss the landscape for increased fraud investigations and enforcement actions related to COVID-19 stimulus spending, including False Claims Act investigations and qui tam whistleblower litigation, as well as steps companies can take to reduce their potential exposure.
Barak, David, and Alex discuss new and emerging enforcement issues related to Paycheck Protection Program loans and other spending under the CARES Act and anticipated areas of focus for the U.S. Department of Justice (DOJ) with respect to the False Claims Act. The episode also provides an overview of recent DOJ fraud enforcement related to COVID-19 and the expected roles to be played by new and existing investigative entities, including the Pandemic Response Accountability Committee and special inspector general for pandemic recovery. Listen to "COVID-19 Relief Fraud Investigations and Litigation: Areas of Focus and Risk Mitigation Strategies" on Spreaker. Note that all episodes are available on Apple, Google, and Spotify.
Print and share
Authors
Explore more in
White Collar Briefly
Drawing from breaking news, ever changing government priorities, and significant judicial decisions, this blog from Perkins Coie’s White Collar and Investigations group highlights key considerations and offers practical insights aimed to guide corporate stakeholders and counselors through an evolving regulatory environment. Subscribe 🡢